CJC-1295 and Ipamorelin are two growth hormone-releasing peptides that are often combined because they work through complementary mechanisms. CJC-1295 is a long-acting growth hormone-releasing hormone (GHRH) analog, while Ipamorelin is a selective growth hormone secretagogue. Together, they encourage the pituitary gland to produce more of your own growth hormone in a pulsatile, physiologically natural pattern.

‍

This combination is popular among patients focused on healthy aging, recovery, and body composition. Unlike synthetic HGH, this approach supports your body's own production, which many patients and clinicians find to be a more balanced and sustainable option.